S&P 500

5.277,51

0,80%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Opthea Ltd (OPT)
Opthea Ltd (OPT) Notícias

OPT

Opthea (OPT)

Opthea Ltd

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:OPT

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
28/05/2024	07:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:OPT	Opthea Ltd
27/12/2023	08:00	GlobeNewswire Inc.	Opthea to Receive US$35M Commitment and Additional US$50M Funding	NASDAQ:OPT	Opthea Ltd
19/12/2023	08:00	GlobeNewswire Inc.	Opthea Receives A$8.8 million R&D Tax Incentive	NASDAQ:OPT	Opthea Ltd
01/12/2023	07:30	GlobeNewswire Inc.	Opthea to Present at the FLORetina 2023 Congress	NASDAQ:OPT	Opthea Ltd
09/11/2023	07:30	GlobeNewswire Inc.	Opthea to Present at the Jefferies 2023 London Healthcare Conference	NASDAQ:OPT	Opthea Ltd
30/10/2023	06:30	GlobeNewswire Inc.	Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference	NASDAQ:OPT	Opthea Ltd
27/10/2023	06:30	GlobeNewswire Inc.	Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO	NASDAQ:OPT	Opthea Ltd
02/10/2023	06:30	GlobeNewswire Inc.	Opthea to Participate at the 2023 Euretina Congress	NASDAQ:OPT	Opthea Ltd
07/09/2023	06:30	GlobeNewswire Inc.	Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:OPT	Opthea Ltd
28/08/2023	06:30	GlobeNewswire Inc.	Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)	NASDAQ:OPT	Opthea Ltd
26/07/2023	07:00	GlobeNewswire Inc.	Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302	NASDAQ:OPT	Opthea Ltd
24/07/2023	07:00	GlobeNewswire Inc.	Opthea to Present at the 2023 Ophthalmology Innovation Summit	NASDAQ:OPT	Opthea Ltd
13/07/2023	07:00	GlobeNewswire Inc.	Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting	NASDAQ:OPT	Opthea Ltd
10/07/2023	07:00	GlobeNewswire Inc.	Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor	NASDAQ:OPT	Opthea Ltd
08/06/2023	07:03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:OPT	Opthea Ltd
08/06/2023	07:00	GlobeNewswire Inc.	Opthea Appoints Anshul Thakral as Non-Executive Director of the Board	NASDAQ:OPT	Opthea Ltd
25/05/2023	09:00	PR Newswire (Canada)	Optiva and lifecell Named as a Nominee in TM Forum's 16th Annual Excellence Awards	NASDAQ:OPT	Opthea Ltd
25/05/2023	07:00	GlobeNewswire Inc.	Opthea to Present at the Jefferies 2023 Healthcare Conference	NASDAQ:OPT	Opthea Ltd
17/05/2023	07:00	GlobeNewswire Inc.	Opthea to Participate in EF Hutton Hosted Discussion on OPT-302 and the Wet AMD Market	NASDAQ:OPT	Opthea Ltd
08/05/2023	06:30	GlobeNewswire Inc.	Opthea To Present at the JMP Securities Life Sciences Conference	NASDAQ:OPT	Opthea Ltd
28/04/2023	06:30	GlobeNewswire Inc.	Opthea To Participate at the H.C. Wainwright BioConnect Conference at NASDAQ	NASDAQ:OPT	Opthea Ltd
07/03/2023	08:00	GlobeNewswire Inc.	Opthea Receives A$8.7 million R&D Tax Incentive	NASDAQ:OPT	Opthea Ltd
06/03/2023	08:00	GlobeNewswire Inc.	Opthea To Participate in Fireside Chat at Oppenheimer’s 33rd Annual Healthcare Conference	NASDAQ:OPT	Opthea Ltd
14/02/2023	18:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OPT	Opthea Ltd
13/02/2023	08:00	GlobeNewswire Inc.	Opthea Phase 2b Trial Results of OPT-302 in Combination with Lucentis® for wet AMD Published in the Journal Ophthalmology	NASDAQ:OPT	Opthea Ltd
06/02/2023	08:00	GlobeNewswire Inc.	Opthea To Present at SVB Leerink Global Biopharma Conference	NASDAQ:OPT	Opthea Ltd
30/01/2023	08:00	GlobeNewswire Inc.	Opthea To Present at Sequire Biotechnology Conference	NASDAQ:OPT	Opthea Ltd
12/12/2022	12:08	GlobeNewswire Inc.	Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD	NASDAQ:OPT	Opthea Ltd
06/12/2022	08:00	GlobeNewswire Inc.	Opthea to Present at the FLORetina 2022 Congress	NASDAQ:OPT	Opthea Ltd
10/11/2022	08:00	GlobeNewswire Inc.	Opthea to Present at Jefferies London Healthcare Conference	NASDAQ:OPT	Opthea Ltd